CN107158029A - A kind of skin care solution - Google Patents
A kind of skin care solution Download PDFInfo
- Publication number
- CN107158029A CN107158029A CN201710419379.3A CN201710419379A CN107158029A CN 107158029 A CN107158029 A CN 107158029A CN 201710419379 A CN201710419379 A CN 201710419379A CN 107158029 A CN107158029 A CN 107158029A
- Authority
- CN
- China
- Prior art keywords
- skin care
- care solution
- skin
- copper
- zinc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000001840 Dandruff Diseases 0.000 claims abstract description 24
- 239000011669 selenium Substances 0.000 claims abstract description 21
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 20
- 150000001875 compounds Chemical class 0.000 claims abstract description 18
- 239000010949 copper Substances 0.000 claims abstract description 17
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229910052802 copper Inorganic materials 0.000 claims abstract description 16
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000011701 zinc Substances 0.000 claims abstract description 10
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 10
- 239000000126 substance Substances 0.000 claims abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 8
- 238000011282 treatment Methods 0.000 claims abstract description 7
- 150000003752 zinc compounds Chemical class 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 229940091258 selenium supplement Drugs 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 11
- -1 ZPT Chemical compound 0.000 claims description 11
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 claims description 9
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 9
- 229940108925 copper gluconate Drugs 0.000 claims description 9
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 8
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 7
- 102000008186 Collagen Human genes 0.000 claims description 5
- 108010035532 Collagen Proteins 0.000 claims description 5
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- 239000004202 carbamide Substances 0.000 claims description 5
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 5
- 229960001471 sodium selenite Drugs 0.000 claims description 5
- 239000011781 sodium selenite Substances 0.000 claims description 5
- 235000015921 sodium selenite Nutrition 0.000 claims description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 4
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 4
- 229960000458 allantoin Drugs 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims description 4
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 4
- 230000003204 osmotic effect Effects 0.000 claims description 4
- 229940101267 panthenol Drugs 0.000 claims description 4
- 239000011619 pantothenol Substances 0.000 claims description 4
- 235000020957 pantothenol Nutrition 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 4
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 4
- 229960001763 zinc sulfate Drugs 0.000 claims description 4
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 4
- 239000002738 chelating agent Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 150000005846 sugar alcohols Polymers 0.000 claims description 3
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- 238000004040 coloring Methods 0.000 claims description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 2
- RNGFNLJMTFPHBS-UHFFFAOYSA-L dipotassium;selenite Chemical compound [K+].[K+].[O-][Se]([O-])=O RNGFNLJMTFPHBS-UHFFFAOYSA-L 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- MGIYRDNGCNKGJU-UHFFFAOYSA-N isothiazolinone Chemical compound O=C1C=CSN1 MGIYRDNGCNKGJU-UHFFFAOYSA-N 0.000 claims description 2
- 235000019136 lipoic acid Nutrition 0.000 claims description 2
- 239000003002 pH adjusting agent Substances 0.000 claims description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 2
- 229940065287 selenium compound Drugs 0.000 claims description 2
- 150000003343 selenium compounds Chemical class 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- 235000013599 spices Nutrition 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 229960002663 thioctic acid Drugs 0.000 claims description 2
- 239000004034 viscosity adjusting agent Substances 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 239000011592 zinc chloride Substances 0.000 claims description 2
- 235000005074 zinc chloride Nutrition 0.000 claims description 2
- GAZOQRUEIUBTNF-UHFFFAOYSA-N 1-[4-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-3-[[[4-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]carbamoylamino]methyl]urea Chemical class N1C(=O)NC(=O)C1(CO)NC(=O)NCNC(=O)NC1(CO)NC(=O)NC1=O GAZOQRUEIUBTNF-UHFFFAOYSA-N 0.000 claims 1
- 229940124091 Keratolytic Drugs 0.000 claims 1
- 150000001805 chlorine compounds Chemical class 0.000 claims 1
- 230000001530 keratinolytic effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 102000004190 Enzymes Human genes 0.000 abstract description 8
- 108090000790 Enzymes Proteins 0.000 abstract description 8
- 230000036542 oxidative stress Effects 0.000 abstract description 6
- 238000005406 washing Methods 0.000 abstract description 6
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 230000005856 abnormality Effects 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 239000011573 trace mineral Substances 0.000 abstract description 3
- 235000013619 trace mineral Nutrition 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 abstract 1
- 229920000832 Cutin Polymers 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 56
- 210000003128 head Anatomy 0.000 description 24
- 239000007788 liquid Substances 0.000 description 18
- 230000003750 conditioning effect Effects 0.000 description 15
- 239000000047 product Substances 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 10
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- WOTIUKDGJBXFLG-UHFFFAOYSA-N 3-methyl-1,2-thiazole Chemical compound CC=1C=CSN=1 WOTIUKDGJBXFLG-UHFFFAOYSA-N 0.000 description 7
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 7
- 235000011478 zinc gluconate Nutrition 0.000 description 7
- 229960000306 zinc gluconate Drugs 0.000 description 7
- 239000011670 zinc gluconate Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 235000013877 carbamide Nutrition 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 3
- FQANRCWINZEGNW-UHFFFAOYSA-N 3-chloro-4-methyl-1,2-thiazole Chemical compound CC1=CSN=C1Cl FQANRCWINZEGNW-UHFFFAOYSA-N 0.000 description 3
- FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical class CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 3
- 229940055619 selenocysteine Drugs 0.000 description 3
- 235000016491 selenocysteine Nutrition 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- NDSJUDPCTYRQFX-UHFFFAOYSA-N 3-chloro-1,2-thiazole Chemical compound ClC=1C=CSN=1 NDSJUDPCTYRQFX-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 101100337673 Caenorhabditis elegans gpx-1 gene Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 2
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 2
- 102000008114 Selenoproteins Human genes 0.000 description 2
- 108010074686 Selenoproteins Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 2
- 229940109529 pomegranate extract Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 229960002718 selenomethionine Drugs 0.000 description 2
- 210000003859 smegma Anatomy 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010019049 Hair texture abnormal Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000011845 Iodide peroxidase Human genes 0.000 description 1
- 108010036012 Iodide peroxidase Proteins 0.000 description 1
- 241000555676 Malassezia Species 0.000 description 1
- 238000000585 Mann–Whitney U test Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 230000037365 barrier function of the epidermis Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 229940079721 copper chloride Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 208000027407 head symptom Diseases 0.000 description 1
- 210000003547 hepatic macrophage Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000003463 hyperproliferative effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
The invention provides a kind of skin care solution, including following component:The 100mg/L of selenium-containing compound 0.1 (in terms of selenium), the 1500mg/L of copper-containing compound 50 (in terms of copper), the mg/L of zinc compound 50 2000 (in terms of zinc) and solvent.Present invention also offers application of the above-mentioned skin care solution in treatment dandruff or the anti-dandruff daily chemical products of the excessive external used medicine of body scurf and head are prepared.The skin care solution of the present invention, trace element supplemented with local skin tissue, improves local cutin formation and promotes cell synthesis SOD enzymes there is provided reproducibility microenvironment, the ability that local skin tackles oxidative stress is improved, promotes the collage synthesis function of local skin tissue.Solve the problem of long-term use washing product containing EDTA causes local skin nutrient imbalance.The skin care solution material of the present invention is easy to get, cost is low, and effect is good, and the scurf that can be effectively improved local skin such as increases at the abnormality, can be widely applied in the anti-dandruff daily chemical products in head.
Description
Technical field
The present invention relates to a kind of skin care solution, belong to field of daily chemicals.
Background technology
Dandruff increases(Dandruff)It is common skin of head dysfunction.So far, scurf increases definite
Pathogenesis is not yet illustrated, it is considered that dandruff increase be multifactor functioning result, risk factor includes:Horse traction color
Bacterium(Malassezia)Propagation, smegma is hyperfunction and private medical service.Wherein private medical service includes:Epidermal barrier it is complete
Whole property, immune response, neural emotion and trophic factor etc..Although may separate out chlosma in scurf(M.globosaWithM. restricta), and accumulative evidence supports the hyper-proliferative of the bacterium to be one of key factor that scurf increases, but simultaneously can be with
Certainly be:The participation of other conditions is indispensable.In recent years, the role of skin-nourishing unbalance factor is increasingly subject to pay attention to,
Achievement in research increasingly increases.
Selenium(Selenium)One of trace element necessary to be humans and animals, selenium constitutes selenoprotein after entering human body.Selenium egg
It is the final form that selenium element realizes its human body physiological function in vain, selenoprotein depth participates in maintaining the normal of each organ-tissue of human body
Physiological function, including skin.SOD enzymes in human body are mainly Cu/Zn-SOD hypotypes, research show copper, the content of zinc with
Corresponding SOD enzyme activity height correlation;And GPx1(Glutathione peroxidase)Activity then with internal Se content height phase
Close.Human body selenium deficiency causes GPx1 activity decrease, tackles oxidative stress reduced capability;Also result in Selenonic protein enzyme --- D3
Enzyme(Iodothyronine deiodinase D3)Activity decrease, causes KCs cells(Hepatic macrophages)Interior T3(Triiodo thyroid gland
Former propylhomoserin)Level rises, and induces KCs Proliferation, Differentiations and adhesion function is abnormal, ultimately result in skin barrier function decline, further
Aggravate the oxidative stress status of local skin.If now human body SOD enzyme activity is not enough(Zinc or copper lack), it is difficult to reply increases severely
Oxidative stress pressure, then local skin the dysfunction state that typical scurf increases can be presented.
Debris removing hair washing product is main to add ZPT as main flow in the market --- pass through antimycotic and supplement
Zn-ef ficiency is effect means.It is single that existing product does not only exist mechanism of action, and often with the common prescriptions of EDTA, have a strong impact on it and dispel
Consider effect to be worth doing, or even have the opposite effect.Therefore, development can correct local skin micro-element nutrition imbalance state, various dimensions reply
Dandruff increases the new care product of mechanism, not the only social demand of reality, and there is potential commercial value.
The content of the invention
Cause local skin nutrient imbalance, current debris removing daily chemical products debris removing to solve to be used for a long time washing product containing EDTA
Effect is poor, the problem of easily recur, and the skin care solution of skin-nourishing imbalance state is improved the invention provides a kind of.
It is excessive in preparation treatment dandruff or body scurf it is a further object of the present invention to provide a kind of above-mentioned skin care solution
External used medicine and hair washing daily chemical products in application.
To achieve the above object, the present invention is adopted the following technical scheme that.
A kind of skin care solution, including following component:Selenium-containing compound 0.1-100 mg/L(In terms of selenium), copper-containing compound
50-1500 mg/L(In terms of copper), zinc compound 50-2000 mg/L(In terms of zinc)And solvent.
Preferably, in the skin care solution, selenium-containing compound 5-50 mg/L(In terms of selenium), copper-containing compound 100-
1000 mg/L(In terms of copper), zinc compound 200-2000 mg/L(In terms of zinc).
The selenium-containing compound, including inorganic selenium and organic selenium compounds, selected from sodium selenite, potassium selenite and
One or more in seleno-amino acids and its derivative.
The copper-containing compound, the one or more in copper gluconate, copper chloride and copper sulphate.
The zinc compound, one kind or one kind in glucose saccharic acid zinc, ZPT, zinc chloride and zinc sulfate
More than.
One or more of the solvent in alcohols, esters, ethers and water.
The skin care solution, in addition to following component:Antioxidant 0.1-50 g/L, preferably 1-10 g/L;Moisturizing
Agent 1-50 g/L.
The antioxidant is selected from natural animal-plant extract, ascorbic acid and its derivative, vitamin E and its derivative
Thing, ubiquinone10, one or more in alpha-lipoic acid and antioxidase preparation.
The NMF be selected from urea, allantoin and its derivative, panthenol, biological polyoses class, collagen, amino acid and
One or more in its derivative and polyalcohol.
The preservative is selected from parabens, isothiazolinone, benzoic acid and its derivative, imidazolidinyl
Ureas, sorbic acid and its salt, phenoxetol, cis- 1-(Chlorallylene base)Azepine -1- nitrogen adamantane the chlorinations of -3,5,7- three
One or more in thing and quaternary ammonium salt -15.
The skin care solution also includes spices, surfactant, colouring agent, viscosity modifier, osmotic pressure regulator, angle
Matter softening agent and pH adjusting agent.
The skin care solution, without metal-chelator.
A kind of application of above-mentioned skin care solution in treatment dandruff or the excessive external used medicine of body scurf is prepared.
A kind of application of above-mentioned skin care solution in the anti-dandruff daily chemical products in head.
The trace elements of selenium that the skin care solution of the present invention, wherein selenium-containing compound are used to supplement local skin tissue is needed
Ask, improve local keratinocyte proliferation and differentiation function;Copper-containing compound is used to supplement local skin with zinc compound
The trace copper and zinc demand of tissue, promote cell synthesis SOD enzymes, improve the ability that local skin tackles oxidative stress;It is anti-
Oxidant is used for one reproducibility microenvironment of structure in local skin tissue, reduces the oxidative stress pressure of local skin, together
When promote local skin tissue collage synthesis function;NMF and osmotic pressure regulator are used to improve oozing for local skin tissue
Pressure, reaches the function of moisturizing thoroughly, promotes the nutrients such as selenium, copper, zinc to penetrate into skin, while it is different also to soften local skin
Normal cuticula;Biological polyoses class, collagen class and polyalcohols composition not only have moisture-keeping function, also viscous with regulation
Degree, the effect of osmotic pressure.
The present invention has advantages below:The skin care solution material of the present invention is easy to get, cost is low, and effect is good, can be effective
The scurf for improving skin especially skin of head such as increases at the abnormality, can be widely applied in the anti-dandruff daily chemical products in head.
Embodiment
With reference to embodiment, the present invention will be further described, but the present invention is not limited by following embodiments.
Embodiment 1
Skin care solution uses formula as below:
The mg of selenomethionine 11.8
The g of copper gluconate 0.73
The g of zinc gluconate 1.40
The g of vitamin C glucoside 1.00
Retinol Palmitate 1.50g
Allantoin 17.0g
Pyrrolidone sodium carboxylate 3.00g
The g of phenoxetol 0.30
The g of methyl-isothiazol 0.05
The mL of glycerine 5.0
The mL of 1,3 butylene glycol 10.0
Water is mended to 1000mL.
Compound method is as follows:
(1)Weigh selenomethionine, copper gluconate, zinc gluconate, vitamin C glucoside, Retinol Palmitate,
Allantoin, pyrrolidone sodium carboxylate, phenoxetol, methyl-isothiazol 800mL water dissolve;
(2)Glycerine, 1,3 butylene glycol are added into above-mentioned steps(1)Solution in, add water to 1000mL, produce skin of head nursing
Liquid.
Embodiment 2
Skin of head conditioning liquid uses formula as below:
Selenocysteine 16.8mg
The g of copper chloride 0.61
Zinc gluconate 4.10g
It is esterified vitamin C 5.00g
Puridoxine hydrochloride 1.00g
Panthenol 10.0g
Magnesium chloride 0.18g
Magnesium nitrate 0.32g
The g of methyl chloroisothiazole 0.15
The g of methyl-isothiazol 0.05
Polyethylene glycol 400 20.0mL
Water is mended to 1000mL.
Compound method is as follows:
(1)Weigh selenocysteine, copper chloride, zinc gluconate, esterification vitamin C, puridoxine hydrochloride, panthenol, magnesium chloride,
Magnesium nitrate, methyl chloroisothiazole and with 800mL water dissolve;
(2)Polyethylene glycol 400 is added into above-mentioned steps(1)Solution in, add water to 1000mL, produce skin of head conditioning liquid.
Embodiment 3
Skin of head conditioning liquid uses formula as below:
The mg of sodium selenite 22.8
The g of copper gluconate 1.50
The g of zinc gluconate 3.00
The g of VCE 2.00
Urea 30.0g
Magnesium chloride 0.18g
Magnesium nitrate 0.42g
The g of methyl chloroisothiazole 0.15
The g of methyl-isothiazol 0.05
The mL of glycerine 5.0
The mL of 1,2- propane diols 10.0
Water is mended to 1000mL.
Compound method is as follows:
(1)Weigh sodium selenite, copper gluconate, zinc gluconate, VCE, urea, magnesium chloride, magnesium nitrate, first
Base chloroisothiazole, methyl-isothiazol 800mL water dissolve;
(2)Glycerine, 1,2- propane diols, preservative liquid are added into above-mentioned steps(1)Solution in, add water to 1000mL, produce head
Portion's skin care solution.
Embodiment 4
Skin of head conditioning liquid uses formula as below:
L- selenium-methyl selenium substituted aminothiopropionics 54.6mg
Copper gluconate 3.63g
Zinc sulfate 1.45g
Co-Q10 0.50g
The mL of pomegranate extract solution 6.5
Glycine betaine 5.0g
Collagen protein powder 10.0g
Methyl hydroxybenzoate 0.70g
Propylben 0.50g
Phenoxetol 0.30g
Xanthans 0.50g
Ethanol 30.0mL
Water is mended to 1000mL.
Compound method is as follows:
(1)Weigh L- selenium-methyl selenium substituted aminothiopropionics, copper gluconate, zinc sulfate, pomegranate extract solution, glycine betaine, collagen
Powder 800mL water dissolves;
(2)By ubiquinone10, methyl hydroxybenzoate, propylben, phenoxetol, xanthans ethanol dissolve after with step(1)
Solution mixing, add water to 1000mL, produce skin of head conditioning liquid.
Embodiment 5
Skin of head conditioning liquid uses formula as below:
Selenocysteine 100.8mg
Sulfuric acid acid copper 2.47g
ZPT 4.76g
Vitamin C glucoside 8.00g
SOD enzymes 2.00g
Hyaluronic acid 10.0g
The g of phenoxetol 0.20
Methyl-isothiazol 0.05g
The mL of ethanol 15.0
Water is mended to 1000mL.
Compound method is as follows:
(1)Weigh sodium selenite, copper gluconate, zinc gluconate, VCE, urea, magnesium chloride, magnesium nitrate, first
Base chloroisothiazole, methyl-isothiazol 800mL water dissolve;
(2)Glycerine, 1,2- propane diols are added into above-mentioned steps(1)Solution in, add water to 1000mL, produce skin of head nursing
Liquid.
The compliance test result of the skin of head conditioning liquid of embodiment 6
The volunteer for participating in experiment is certain working unit personnel, there is skin of head symptom.Test group 12, control group 8.
Main header skin symptom is as follows:Long-term existence dandruff increases, and with dry scalp or the vigorous phenomenon of smegma, occasionally has
Pruritis;Local inflammation focus is rare.
2.1 application method
Test group uses skin of head conditioning liquid in embodiment 3 as follows, continues 21 days.
(1)Stop using the washing product containing EDTA and its salt or his metal-chelator;
(2)Overhead skin is squirted using this product once, every time 2.5 mL or so daily(General 20-25 is pressed), by head skin
Skin is uniformly squirted as standard, is dried naturally;
(3)Hair washing is finished every time, is wiped and is used this product after dry hair immediately.
Control group localized pulverization uses the control sample being made up of pure water, uses 21 days.
2.2 using effects are evaluated
The using effect of skin of head conditioning liquid is evaluated according to following evaluation criteria, using effect data are shown in Table 1.
(1)Syndrome Scale and skin of head conditioning liquid effective evaluation standard
Syndrome Scale quantitative criteria
The skin of head Syndrome Scale standard of table 1
Skin of head conditioning liquid using effect evaluation criteria
Comprehensive therapeutic effect index=[(Integrated before treatment after integration-treatment)Integrated before ÷ treatments] × 100%.
Recovery from illness:Symptom disappears after medication, and integrated value reduces >=95%.
It is effective:Symptom is obviously improved after medication, and integrated value reduces >=70%.
Take a turn for the better:Symptom improves after medication, and integrated value reduces >=30%.
It is invalid:Symptom is not improved after medication, or integrated value reduces < 30%.
Recovery from illness will finally be counted as " effective " with effective.
(2)Skin of head conditioning liquid using effect
All volunteers for participating in this experiment complete using effect experience, and test data is as follows:
The skin of head conditioning liquid antidandruff efficacy of table 2
According to the data of table 2, skin of head conditioning liquid of the invention uses 14 days effective percentage to be 68.75%, and effective percentage is within 21 days
87.50%, compared with blank control, there is conspicuousness in difference(P<0.05, Wilcoxon rank sum test)And experimental period
Between do not occur adverse reaction.Test data shows that skin of head conditioning liquid of the invention can be effectively improved the skin of skin of head
Bits such as increase at the abnormality.
Claims (8)
1. a kind of skin care solution, it is characterised in that including following component:Selenium-containing compound 0.1-100 mg/L(In terms of selenium),
Copper-containing compound 50-1500 mg/L(In terms of copper), zinc compound 50-2000 mg/L(In terms of zinc)And solvent.
2. skin care solution according to claim 1, it is characterised in that the selenium-containing compound, including inorganic selenium chemical combination
Thing and organic selenium compounds, one kind in sodium selenite, potassium selenite and seleno-amino acids and its derivative or it is a kind of with
On;
The copper-containing compound, the one or more in copper gluconate, copper chloride and copper sulphate;
The zinc compound, one kind in glucose saccharic acid zinc, ZPT, zinc chloride and zinc sulfate or it is a kind of with
On;
One or more of the solvent in alcohols, esters, ethers and water.
3. skin care solution according to claim 1, it is characterised in that also including following component:Antioxidant 0.1-50
G/L, NMF 1-50 g/L and preservative.
4. skin care solution according to claim 3, it is characterised in that the antioxidant is extracted selected from natural animal-plant
Thing, ascorbic acid and its derivative, vitamin E and its derivative, ubiquinone10, one kind in alpha-lipoic acid and antioxidase preparation
Or more than one;
The NMF is selected from urea, allantoin and its derivative, panthenol, biological polyoses class, collagen, amino acid and its spread out
One or more in biological and polyalcohol;
The preservative is selected from parabens, isothiazolinone, benzoic acid and its derivative, imidazolidinyl urea
Class, sorbic acid and its salt, phenoxetol, cis- 1-(Chlorallylene base)Azepine -1- nitrogen adamantane the chlorides of -3,5,7- three
With the one or more in quaternary ammonium salt -15.
5. according to any described skin care solution of claim 1 or 3, it is characterised in that also including spices, surfactant,
Colouring agent, viscosity modifier, osmotic pressure regulator, keratolytic, pH adjusting agent.
6. according to any described skin care solution in claim 1,3 or 5, it is characterised in that without metal-chelator.
7. a kind of skin care solution as described in claim 1-6 is any is preparing treatment dandruff or the excessive external application of body scurf
Application in medicine.
8. a kind of application of skin care solution as described in claim 1-6 is any in the anti-dandruff daily chemical products in head.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710419379.3A CN107158029A (en) | 2017-06-06 | 2017-06-06 | A kind of skin care solution |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710419379.3A CN107158029A (en) | 2017-06-06 | 2017-06-06 | A kind of skin care solution |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107158029A true CN107158029A (en) | 2017-09-15 |
Family
ID=59824591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710419379.3A Pending CN107158029A (en) | 2017-06-06 | 2017-06-06 | A kind of skin care solution |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107158029A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110893171A (en) * | 2019-12-30 | 2020-03-20 | 济源市万洋华康生物科技有限公司 | Preparation method of composition for inhibiting wound cicatricial healing |
CN114848522A (en) * | 2022-05-24 | 2022-08-05 | 华南农业大学 | Application of selenomethionine in preparation of skin care product |
CN115040446A (en) * | 2022-06-24 | 2022-09-13 | 曾会明 | SOD plant extract skin care composition, skin care product and preparation method thereof |
FR3144756A1 (en) * | 2023-01-09 | 2024-07-12 | L'oreal | SCALP CARE COMPOSITION COMPRISING A LIPOPHILIC SOLID ACTIVE AGENT, A MONOALCOHOL AND A HYDROPHILIC THICKENER |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61233608A (en) * | 1985-04-10 | 1986-10-17 | Shiseido Co Ltd | Hair cosmetic |
CN1414846A (en) * | 1999-06-25 | 2003-04-30 | 宝洁公司 | Topical anti-microbial compositions |
CN103735421A (en) * | 2013-12-24 | 2014-04-23 | 董延昌 | Anti-skin-aging composition and preparation method thereof |
-
2017
- 2017-06-06 CN CN201710419379.3A patent/CN107158029A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61233608A (en) * | 1985-04-10 | 1986-10-17 | Shiseido Co Ltd | Hair cosmetic |
CN1414846A (en) * | 1999-06-25 | 2003-04-30 | 宝洁公司 | Topical anti-microbial compositions |
CN103735421A (en) * | 2013-12-24 | 2014-04-23 | 董延昌 | Anti-skin-aging composition and preparation method thereof |
Non-Patent Citations (7)
Title |
---|
史培圣: "《实用现代顺势医学》", 28 February 2014, 中医古籍出版社 * |
吴少雄,等: "《营养学》", 28 February 2012 * |
宋小平,等: "《实用化学品配方手册 (八)》", 31 January 1997, 四川科学技术出版社 * |
常学辉: "《家庭医学健康百科全书》", 31 October 2014, 天津科学技术出版社 * |
罗明泉,等: "《常见有毒和危险化学品手册》", 31 July 1992, 中国轻工业出版社 * |
范正祥,等: "《农家卫生指南》", 28 February 1985, 河南科学技术出版社 * |
顾学箕: "《中国医学百科全书 毒理学》", 31 August 1982, 上海科学技术出版社 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110893171A (en) * | 2019-12-30 | 2020-03-20 | 济源市万洋华康生物科技有限公司 | Preparation method of composition for inhibiting wound cicatricial healing |
CN110893171B (en) * | 2019-12-30 | 2021-07-27 | 河南希百康健康产业有限公司 | Preparation method of composition for inhibiting wound cicatricial healing |
CN114848522A (en) * | 2022-05-24 | 2022-08-05 | 华南农业大学 | Application of selenomethionine in preparation of skin care product |
CN115040446A (en) * | 2022-06-24 | 2022-09-13 | 曾会明 | SOD plant extract skin care composition, skin care product and preparation method thereof |
FR3144756A1 (en) * | 2023-01-09 | 2024-07-12 | L'oreal | SCALP CARE COMPOSITION COMPRISING A LIPOPHILIC SOLID ACTIVE AGENT, A MONOALCOHOL AND A HYDROPHILIC THICKENER |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Piquero-Casals et al. | Topical non-pharmacological treatment for facial seborrheic dermatitis | |
CN107158029A (en) | A kind of skin care solution | |
US20040156873A1 (en) | Topically Bioavailable Acne and Rosacea Treatment Compositions | |
RO120122B1 (en) | Medical composition and use thereof as medicine in topical barrier formulation, a uv-radiation absorbing formulation or an antiviral, antifungal or aniinflammatory formulation | |
MX2011010126A (en) | Binary and tertiary galvanic particulates and methods of manufacturing and use thereof. | |
CN112691049B (en) | Shampoo composition containing zinc hyaluronate | |
US20060269615A1 (en) | Topical treatment for skin irritation | |
CN108992357A (en) | A kind of anti-dandruff and itching-relieving shampoo containing silk hydroiyzing liquid | |
US20070269534A1 (en) | Methods of treating skin to enhance therapeutic treatment thereof | |
CN107028797A (en) | Anti-acne essence and preparation method thereof | |
CN110302081A (en) | A kind of dual sodium hyaluronate stoste and preparation method thereof | |
Klock et al. | Sodium ascorbyl phosphate shows in vitro and in vivo efficacy in the prevention and treatment of acne vulgaris | |
CN105381454B (en) | A kind of nasal cavity wetting agent containing trehalose | |
Tunku Mahmud et al. | A review on the potential use of chitosan-based delivery system in mild facial cleansing formulation | |
EP1818064A2 (en) | Methods of treating skin to enhance therapeutic treatment thereof | |
CN104053425B (en) | Medical science skin care compositions based on collargol and the synergistic combination of DNA (deoxyribonucleic acid) | |
CN110917058A (en) | Cosmetic agent for relieving skin irritation and preparation method thereof | |
CN116236432A (en) | Preparation method of anti-inflammatory and spot-fading essence and anti-inflammatory and spot-fading essence prepared by same | |
CN110507557A (en) | Fat-soluble toothpaste | |
US8980336B2 (en) | Method for inhibiting free radicals | |
CN103251517A (en) | Applications of zinc glycyrrhetate, and zinc glycyrrhetate-containing composition | |
WO2019056725A1 (en) | Preservative-free mask | |
CN103242392A (en) | Novel glycyrrhizic acid double salt, and preparation and application thereof | |
JPH07267869A (en) | Remedy and method for medical treatment for dermatosis | |
JPH09227387A (en) | Drug externally using for treatment of atopic dermatitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170915 |